DMS released its H1 16 results. Revenues reached €17.2m (+15.7%), EBITDA €41k (vs €-707k), operating result €-402k (vs €-1.16m) and net result (group share) €-459k (vs €-786k). The group had €6.2m in available cash at the end of June (€6.1m of gross debt, and €0.1m in net cash) vs €7.3m a year ago. It confirmed its target of outperforming the market on its historical business (imaging) while progressing with the synergies with AXS M&eacut
03 Oct 2016
H1 16 : well in line with our numbers
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
H1 16 : well in line with our numbers
Diagnostic Medical Systems (0RIA:LON) | 0 0 0.0%
- Published:
03 Oct 2016 -
Author:
Fabrice Farigoule -
Pages:
3
DMS released its H1 16 results. Revenues reached €17.2m (+15.7%), EBITDA €41k (vs €-707k), operating result €-402k (vs €-1.16m) and net result (group share) €-459k (vs €-786k). The group had €6.2m in available cash at the end of June (€6.1m of gross debt, and €0.1m in net cash) vs €7.3m a year ago. It confirmed its target of outperforming the market on its historical business (imaging) while progressing with the synergies with AXS M&eacut